Global burden of metabolic diseases, 1990–2021

2024-11-1

Identifying genetic determinants of sarcopenia-related traits: a Mendelian randomization study of druggable genes

2024-11-1

Longitudinal proteomics of leptin treatment in humans with acute and chronic energy deficiency-induced hypoleptinemia reveal novel, mainly immune-related, pleiotropic effects

2024-10-1

Regional gray matter changes in steatotic liver disease provide a neurobiological link to depression: A cross-sectional UK biobank cohort study

2024-10-1

Editorial Board

2024-10-1

Cardiomyocyte LGR6 alleviates ferroptosis in diabetic cardiomyopathy via regulating mitochondrial biogenesis

2024-10-1

Cannabinoid receptor 2 plays a key role in renal fibrosis through inhibiting lipid metabolism in renal tubular cells

2024-10-1

Editorial Board

2024-9-10

Copper impairs the intestinal barrier integrity in Wilson disease

2024-9-1

Lactate and lactylation in cardiovascular diseases: current progress and future perspectives

2024-9-1

Estrogen receptor-α signaling in tanycytes lies at the crossroads of fertility and metabolism

2024-9-1

Diacylglycerol kinase delta overexpression improves glucose clearance and protects against the development of obesity

2024-9-1

Metabolic reprogramming in septic acute kidney injury: pathogenesis and therapeutic implications

2024-9-1

Intricate interplay between cell metabolism and necroptosis regulation in metabolic dysfunction-associated steatotic liver disease: A narrative review

2024-9-1

Editorial Board

2024-9-1

The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: an international multidisciplinary expert consensus

2024-9-1

Life's essential 8 and cardiovascular diseases progression among adults in the United Kingdom

2024-9-1

Beyond glucose: The crucial role of redox signaling in β-cell metabolic adaptation

2024-9-1

History and future of leptin: Discovery, regulation and signaling

2024-9-1

Fasting-induced miR-7a-5p in AgRP neurons regulates food intake

2024-9-1

New insights into the function of the NLRP3 inflammasome in sarcopenia: mechanism and therapeutic strategies

2024-9-1

Steatotic liver disease in the context of hematological malignancies and anti-neoplastic chemotherapy

2024-8-12

Targeting the regulation of iron homeostasis as a potential therapeutic strategy for nonalcoholic fatty liver disease

2024-8-1

Management of patients with the cardio renal liver metabolic syndrome: The need for a multidisciplinary approach in research, education and practice

2024-8-1

Fueling the fight against cancer: Exploring the impact of branched-chain amino acid catalyzation on cancer and cancer immune microenvironment

2024-8-1

Hepatic noradrenergic innervation acts via CREB/CRTC2 to activate gluconeogenesis during cold

2024-8-1

Editorial Board

2024-8-1

Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?

2024-8-1

Placental growth factor deficiency initiates obesity- and aging-associated metabolic syndrome

2024-8-1

Metabolic dysfunction-associated steatotic liver disease: Recent turning points for its diagnosis and management

2024-8-1

Metabolic dysfunction-associated steatotic liver disease and extrahepatic gastrointestinal cancers

2024-8-1

The evolutionary conserved miR-137/325 tandem mediates obesity-induced hypogonadism and metabolic comorbidities by repressing hypothalamic kisspeptin

2024-8-1

Diagnostics and omics technologies for the detection and prediction of metabolic dysfunction-associated steatotic liver disease-related malignancies

2024-8-1

cGAS suppresses β-cell proliferation by a STING-independent but CEBPβ-dependent mechanism

2024-8-1

Targeting endothelial KCa channels in vivo restores arterial and endothelial function in type 2 diabetic rats

2024-8-1

Adipose tissue in older individuals: a contributing factor to sarcopenia

2024-8-1

Global, regional, and national trends in metabolic risk factor-associated mortality among the working-age population from 1990-2019: An age-period-cohort analysis of the Global Burden of Disease 2019 study

2024-8-1

Regulation of hepatic lipogenesis by asymmetric arginine methylation

2024-8-1

Metabolic dysfunction-associated steatotic liver disease and its link to cancer

2024-8-1

Estradiol contributes to sex differences in resilience to septic-induced metabolic dysregulation and dysfunction in the heart via GPER-1-mediated PPARδ/NLRP3 signaling

2024-7-1

Editorial Board

2024-7-1

RIPK3 causes mitochondrial dysfunction and albuminuria in diabetic podocytopathy through PGAM5-Drp1 signaling

2024-7-1

Increased adrenal steroidogenesis and suppressed corticosteroid responsiveness in critical COVID-19

2024-7-1

Suppression of RCAN1 alleviated lipid accumulation and mitochondrial fission in diabetic cardiomyopathy

2024-7-1

Association of fatty liver index with sudden cardiac arrest in young adults

2024-7-1

Virus-induced diabetes mellitus, revisiting infection etiology in light of SARS-CoV-2

2024-7-1

Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: systematic analysis from the global burden of disease study 2019

2024-6-26

Dr. James B. Field: An obituary (1926 – 2023)

2024-6-22

The lipopolysaccharide-TLR4 axis regulates hepatic glutaminase 1 expression promoting liver ammonia build-up as steatotic liver disease progresses to steatohepatitis

2024-6-19

Characterization of the plasma metabolome and lipidome in response to sleeve gastrectomy and gastric bypass surgeries reveals molecular patterns of surgical weight loss

2024-6-19